![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 401/14 | (2006.01) |
A61P 31/18 | (2006.01) | ||
A61K 31/4439 | (2006.01) |
(11) | Number of the document | 3347352 |
(13) | Kind of document | T |
(96) | European patent application number | 17758388.7 |
Date of filing the European patent application | 2017-08-17 | |
(97) | Date of publication of the European application | 2018-07-18 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
(46) | Date of publication of the claims translation | 2019-08-12 |
(86) | Number | PCT/US2017/047416 |
Date | 2017-08-17 |
(87) | Number | WO 2018/035359 |
Date | 2018-02-22 |
(30) | Number | Date | Country code |
201662377312 P | 2016-08-19 | US | |
201762457555 P | 2017-02-10 | US |
(72) |
GRAUPE, Michael, US
HENRY, Steven J., US
LINK, John O., US
ROWE, Charles William, US
SAITO, Roland D., US
SCHROEDER, Scott D., US
STEFANIDIS, Dimitrios, US
TSE, Winston C., US
ZHANG, Jennifer R., US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Terapiniai junginiai, naudotini ŽIV viruso infekcijos profilaktikai arba terapiniam gydymui |
THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION |
Payment date | Validity (years) | Amount | |
2025-07-23 | 9 | 208.00 EUR |
2026-08-17 |